Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.620
+0.070 (4.52%)
Nov 21, 2024, 4:00 PM EST - Market closed

Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $61.03 million. The enterprise value is $50.48 million.

Market Cap 61.03M
Enterprise Value 50.48M

Important Dates

The last earnings date was Friday, November 8, 2024, after market close.

Earnings Date Nov 8, 2024
Ex-Dividend Date n/a

Share Statistics

Entera Bio has 36.83 million shares outstanding. The number of shares has increased by 22.42% in one year.

Current Share Class 36.83M
Shares Outstanding 36.83M
Shares Change (YoY) +22.42%
Shares Change (QoQ) +1.49%
Owned by Insiders (%) 2.22%
Owned by Institutions (%) 3.91%
Float 26.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 8.77
P/TBV Ratio 8.85
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 509.94
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.05.

Current Ratio 6.61
Quick Ratio 6.26
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -144.67% and return on invested capital (ROIC) is -85.93%.

Return on Equity (ROE) -144.67%
Return on Assets (ROA) -70.61%
Return on Capital (ROIC) -85.93%
Revenue Per Employee $5,500
Profits Per Employee -$509,889
Employee Count 18
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +112.33% in the last 52 weeks. The beta is 1.59, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y) 1.59
52-Week Price Change +112.33%
50-Day Moving Average 1.84
200-Day Moving Average 1.82
Relative Strength Index (RSI) 31.37
Average Volume (20 Days) 130,999

Short Selling Information

Short Interest 44,153
Short Previous Month 40,395
Short % of Shares Out 0.12%
Short % of Float 0.17%
Short Ratio (days to cover) 1.98

Income Statement

In the last 12 months, Entera Bio had revenue of $99,000 and -$9.18 million in losses. Loss per share was -$0.26.

Revenue 99,000
Gross Profit 9,000
Operating Income -9.21M
Pretax Income -8.51M
Net Income -9.18M
EBITDA -9.16M
EBIT -9.21M
Loss Per Share -$0.26
Full Income Statement

Balance Sheet

The company has $6.92 million in cash and $309,000 in debt, giving a net cash position of $6.61 million or $0.18 per share.

Cash & Cash Equivalents 6.92M
Total Debt 309,000
Net Cash 6.61M
Net Cash Per Share $0.18
Equity (Book Value) 6.45M
Book Value Per Share 0.18
Working Capital 6.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.97 million and capital expenditures -$5,000, giving a free cash flow of -$7.97 million.

Operating Cash Flow -7.97M
Capital Expenditures -5,000
Free Cash Flow -7.97M
FCF Per Share -$0.22
Full Cash Flow Statement

Margins

Gross Margin 9.09%
Operating Margin -9,304.04%
Pretax Margin -9,270.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -12,884.21%

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.42%
Shareholder Yield -22.42%
Earnings Yield -16.08%
FCF Yield -13.97%

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 503.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 503.50%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Entera Bio has an Altman Z-Score of 0.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.12
Piotroski F-Score 3